tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ATOS Stock Latest News

Atossa Therapeutics Appoints Heather Rees as Chief Financial Officer
Press ReleasesAtossa Therapeutics Appoints Heather Rees as Chief Financial Officer
19d ago
ATOS
Atossa Therapeutics appoints Heather Rees as CFO
PremiumThe Fly
Atossa Therapeutics appoints Heather Rees as CFO
19d ago
ATOS
Atossa announces updated protocol for trial of (Z)-Endoxifen with abemaciclib
PremiumThe Fly
Atossa announces updated protocol for trial of (Z)-Endoxifen with abemaciclib
24d ago
LLY
ATOS
Atossa Therapeutics Announces Updated Protocol for Clinical Trial Evaluating (Z)-Endoxifen in Combination with Abemaciclib (VERZENIO®) in Women with ER+/HER2- Breast Cancer
PremiumPress Releases
Atossa Therapeutics Announces Updated Protocol for Clinical Trial Evaluating (Z)-Endoxifen in Combination with Abemaciclib (VERZENIO®) in Women with ER+/HER2- Breast Cancer
24d ago
ATOS
Atossa Therapeutics set to join Russell 3000 Index
PremiumThe Fly
Atossa Therapeutics set to join Russell 3000 Index
1M ago
ATOS
Atossa Set to Join Russell 3000® Index Effective June 28, 2024
PremiumPress ReleasesAtossa Set to Join Russell 3000® Index Effective June 28, 2024
1M ago
ATOS
Atossa to Present at the Sidoti Small-Cap Investor Conference
PremiumPress Releases
Atossa to Present at the Sidoti Small-Cap Investor Conference
2M ago
ATOS
Atossa Therapeutics Announces Support of Clinical Study Testing New, Artificial Intelligence, Breast Cancer Risk Assessment Model
PremiumPress Releases
Atossa Therapeutics Announces Support of Clinical Study Testing New, Artificial Intelligence, Breast Cancer Risk Assessment Model
2M ago
ATOS
Atossa Therapeutics announces support for Phase 2 SMART study
PremiumThe Fly
Atossa Therapeutics announces support for Phase 2 SMART study
2M ago
ATOS
Atossa announces last patient, last dose in Phase 2 Karisma-Endoxifen trial
PremiumThe Fly
Atossa announces last patient, last dose in Phase 2 Karisma-Endoxifen trial
2M ago
ATOS
Atossa Therapeutics Announces Last Patient, Last Dose in its Phase 2 Karisma-Endoxifen Clinical Trial
PremiumPress Releases
Atossa Therapeutics Announces Last Patient, Last Dose in its Phase 2 Karisma-Endoxifen Clinical Trial
2M ago
ATOS
Atossa Therapeutics files $100M mixed securities shelf
PremiumThe Fly
Atossa Therapeutics files $100M mixed securities shelf
2M ago
ATOS
Atossa Therapeutics price target raised to $6 from $4 at H.C. Wainwright
PremiumThe FlyAtossa Therapeutics price target raised to $6 from $4 at H.C. Wainwright
2M ago
ATOS
Atossa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
PremiumPress Releases
Atossa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
2M ago
ATOS
Atossa Therapeutics reports Q1 EPS (5c), consensus (7c)
PremiumThe Fly
Atossa Therapeutics reports Q1 EPS (5c), consensus (7c)
2M ago
ATOS
Atossa Therapeutics announce support of new breast cancer screening guidelines
PremiumThe Fly
Atossa Therapeutics announce support of new breast cancer screening guidelines
3M ago
ATOS
Atossa Therapeutics Announces Support of New Breast Cancer Screening Guidelines
PremiumPress Releases
Atossa Therapeutics Announces Support of New Breast Cancer Screening Guidelines
3M ago
ATOS
Atossa Therapeutics Announces Expanded Research Agreement with Weill Cornell Medicine to Further Evaluate Synergy Between Antibody Drug Conjugates (ADCs) and (Z)-Endoxifen
PremiumPress Releases
Atossa Therapeutics Announces Expanded Research Agreement with Weill Cornell Medicine to Further Evaluate Synergy Between Antibody Drug Conjugates (ADCs) and (Z)-Endoxifen
3M ago
ATOS
Atossa announces expanded research agreement with Weill Cornell Medicine
PremiumThe Fly
Atossa announces expanded research agreement with Weill Cornell Medicine
3M ago
ATOS
Atossa Therapeutics and Quantum Leap Healthcare Announce I-SPY 2 Clinical Trial to Evaluate (Z)-Endoxifen in Combination with Abemaciclib (VERZENIO®) in Women with ER+/HER2- Breast Cancer
PremiumPress ReleasesAtossa Therapeutics and Quantum Leap Healthcare Announce I-SPY 2 Clinical Trial to Evaluate (Z)-Endoxifen in Combination with Abemaciclib (VERZENIO®) in Women with ER+/HER2- Breast Cancer
3M ago
ATOS
Atossa Therapeutics, Quantum Leap announces initiation of I-SPY 2 trial
PremiumThe Fly
Atossa Therapeutics, Quantum Leap announces initiation of I-SPY 2 trial
3M ago
ATOS
Atossa to Participate in Noble Capital Markets Emerging Growth Healthcare Conference
PremiumPress Releases
Atossa to Participate in Noble Capital Markets Emerging Growth Healthcare Conference
3M ago
ATOS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >